Business Segments · Net Sales
Cardiovascular — Net Sales
Boston Scientific Cardiovascular — Net Sales increased by 4.0% to $3.48B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 18.2%, from $2.94B to $3.48B. Over 4 years (FY 2021 to FY 2025), Cardiovascular — Net Sales shows an upward trend with a 28.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025
Rolls up toTotal Revenue
How to read this metric
An increase indicates strong market adoption, successful product launches, or effective sales execution within the cardiovascular space.
Detailed definition
This metric measures the total revenue generated from the sale of cardiovascular medical devices after deductions for re...
Peer comparison
Standard 'Segment Revenue' metric used by all public companies to report divisional performance.
Metric ID:
bsx_segment_cardiovascular_net_salesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.26B | $1.20B | $1.27B | $1.87B | $2.00B | $1.96B | $2.00B | $2.11B | $2.24B | $2.19B | $2.29B | $2.45B | $2.64B | $2.73B | $2.94B | $3.09B | $3.35B | $3.34B | $3.48B |
| QoQ Change | — | -5.3% | +6.2% | +47.5% | +6.6% | -1.9% | +2.3% | +5.3% | +6.1% | -2.4% | +4.6% | +7.0% | +7.9% | +3.6% | +7.7% | +4.9% | +8.4% | -0.1% | +4.0% |
| YoY Change | — | — | — | — | +58.0% | +63.7% | +57.8% | +12.7% | +12.2% | +11.6% | +14.0% | +15.9% | +17.8% | +25.0% | +28.8% | +26.2% | +26.8% | +22.4% | +18.2% |
Range$1.20B – $3.48B
CAGR+25.2%
Avg YoY Growth+27.4%
Median YoY Growth+22.4%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's cardiovascular — net sales?
- Boston Scientific (BSX) reported cardiovascular — net sales of $3.48B in Q4 2025.
- How has Boston Scientific's cardiovascular — net sales changed year-over-year?
- Boston Scientific's cardiovascular — net sales increased by 18.2% year-over-year, from $2.94B to $3.48B.
- What is the long-term trend for Boston Scientific's cardiovascular — net sales?
- Over 4 years (2021 to 2025), Boston Scientific's cardiovascular — net sales has grown at a 28.5% compound annual growth rate (CAGR), from $4.86B to $13.25B.
- What does cardiovascular — net sales mean?
- Total revenue generated by the cardiovascular business segment.